A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)

This study has been completed.

Study NCT00136409 Information provided by Dana-Farber Cancer Institute

First Received: August 25, 2005 Last Updated: March 9, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2008
Primary Completion Date:	August 2005 (Final data collection date for primary outcome measure)